QIM
IART icon

Quantitative Investment Management’s Integra LifeSciences IART Stock Holding History

Quantitative Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-17,346
Closed -$968K – 674
2019
Q2 		$968K Buy
+17,346
New +$893K 0.04% 418
2019
Q1 		– Sell
-20,100
Closed -$906K – 732
2018
Q4 		$906K Buy
+20,100
New +$1.1M 0.05% 297
2018
Q2 		– Sell
-11,000
Closed -$608K – 823
2018
Q1 		$608K Buy
+11,000
New +$577K 0.01% 628

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Quantitative Investment Management's IART Position: Q3 2019 in Review

Quantitative Investment Management sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 17,346 shares — an estimated $968K sold.

Quantitative Investment Management first reported a position in IART in Q1 2018 and held it in 3 quarters. The position peaked at $968K in Q2 2019. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

  • Quantitative Investment Management reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
  • Quantitative Investment Management sold 17,346 Integra LifeSciences shares in Q3 2019, an estimated $968K.
  • Quantitative Investment Management first reported a position in Integra LifeSciences in Q1 2018 and held it in 3 quarters.
  • Quantitative Investment Management's Integra LifeSciences position peaked at $968K in Q2 2019.
  • 280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Quantitative Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.